3021, 3321 – D-Dimer Latex

Fibrinolysis and Blood Coagulation

Fibrinolysis, the catalytic breakdown of fibrin in blood clots, is an important component of the regulation of blood coagulation and plays a crucial role in the removal of thrombi. During the coagulation process, activation of thrombin converts the soluble plasma protein fibrinogen into fibrin. This fibrin initially polymerizes to form a non–cross-linked, soluble fibrin gel.

Subsequently, thrombin activates coagulation factor XIII, which stabilizes the fibrin network by forming cross-links between fibrin fibers. This process transforms the soluble fibrin gel into a stable and insoluble fibrin clot that contributes to effective hemostasis. At the same time, the fibrinolytic pathway is initiated, leading to the formation of plasmin, the principal enzyme responsible for clot degradation.

Formation of D-Dimer

The fibrinolytic enzyme plasmin cleaves both fibrinogen and fibrin into smaller degradation products. However, only the degradation of cross-linked fibrin generates specific fragments known as D-Dimer. These fragments originate from cross-linked fibrin degradation products (XL-FDP) and therefore indicate that fibrin clot formation and subsequent breakdown have occurred.

Because D-Dimer is produced exclusively from the degradation of cross-linked fibrin, it serves as an important diagnostic marker for activated coagulation and fibrinolysis. Measurement of D-Dimer levels in blood is widely used in clinical diagnostics to support the detection or exclusion of thrombotic disorders. Elevated D-Dimer levels can indicate increased clot formation and breakdown in the body and therefore provide valuable information in the assessment of conditions associated with abnormal blood clotting.